Related Experiment Video
Updated: Jun 3, 2025

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
In Silico Evaluation of Potential NDM-1 Inhibitors: An Integrated Docking and Molecular Dynamics Approach
Eduvan Valencia1, Mauricio Galvis2,3, Jorge Nisperuza2
1Departamento de Química, Universidad Nacional de Colombia, Bogotá 111321, Colombia.
Computational methods identified novel NDM-1 carbapenemase inhibitors. Molecule M26 showed strong binding affinity and potential for developing new antibiotics against resistant bacteria.
Area of Science:
- * Computational chemistry and structural biology.
Background:
- * Non-fermenting Gram-negative bacteria exhibit high antibiotic resistance, often due to enzymes like New Delhi metallo-beta-lactamase (NDM-1).
- * Developing novel inhibitors against NDM-1 is crucial for combating antimicrobial resistance.
Purpose of the Study:
- * To identify effective small molecule inhibitors against the NDM-1 enzyme using computational approaches.
- * To optimize the discovery process for new lead molecules targeting NDM-1.
Main Methods:
- * Utilized molecular docking with AutoDock4/AutoDock4Zn and molecular dynamics (MD) simulations with GROMACS.
- * Protein and ligand preparation involved UCSF Chimera, AutoDockTools, MarvinSketch, and Avogadro.
- * Assessed binding energy affinities and conformational stability of enzyme-inhibitor complexes.
Main Results:
- * Molecular docking identified M26 and M25 as top candidates with significant binding energy affinities to NDM-1.
- * Molecule M26 demonstrated strong binding, forming six hydrogen bonds with the NDM-1 enzyme.
- * MD simulations confirmed conformational stability and flexibility for NDM-1 complexes with M26, M35, and M37.
Conclusions:
- * Ligands M26, M37, and M35 show considerable potential as lead compounds for novel NDM-1 inhibitors.
- * These identified compounds may offer advantages over existing antibiotics like Meropenem in certain aspects.
More Related Videos
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015